Net sales rose 4.9% to CHF 5.5 billion in H1 2026, with Core EBIT up 3.6% and EPS up 10.6%. Strong cash flow, robust M&A activity, and investments in AI and sustainability support a positive outlook, especially in healthcare and technology.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.